MYLAN 233 (Efavirenz 600 mg)
Pill imprint MYLAN 233 has been identified as Efavirenz 600 mg.
Efavirenz is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about efavirenz
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 7 Reviews – Add your own review/rating
- Drug class: NNRTIs
Other brands: Sustiva
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.